Welcome to our dedicated page for So-Young International American Depository Shares news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young International American Depository Shares stock.
So-Young International Inc. (symbol: SY) operates a leading online platform for medical aesthetics and elective healthcare services. Established in China, the company focuses on providing users with reliable information about medical aesthetic procedures. Through its platform, users can discover content, share personal experiences, and reserve treatment services from vetted medical aesthetic providers. This service is available not only in China but also internationally.
So-Young's business model includes four key components: distribution of professional content via social media and targeted media platforms, a vibrant social community rich in user-generated content, online reservation services for medical aesthetic treatments, and the research, development, and sales of medical beauty equipment. The company generates revenue through information service fees and reservation fees from its network of approximately 6,100 medical aesthetic service providers.
In addition to aesthetical treatments, So-Young facilitates user reservations for a broad range of medical services, including dermatology, dentistry, ophthalmology, gynecology, HPV vaccinations, and postnatal care.
Recent achievements include several strategic developments and new partnerships. For instance, in November 2023, So-Young reported strong financial results with a 19.2% increase in total revenues year-over-year to RMB385.3 million. In December 2023, the company announced a significant partnership with Healtech to develop regenerative medical aesthetic products, marking a major step in expanding their supply chain business.
Additionally, the leadership team has undergone recent changes to bolster expertise and drive growth. As of October 2023, the board appointed Ms. Nan Shen, a seasoned financial expert, as an independent director. This appointment aligns with So-Young's commitment to reinforcing internal growth and maintaining high standards of governance.
Financially, So-Young has demonstrated resilience despite macroeconomic challenges, achieving a net income of RMB18.3 million in the third quarter of 2023. The company maintains a strong cash position with RMB1,405.4 million in cash, cash equivalents, restricted cash, and short-term investments as of September 30, 2023.
Leveraging its strong brand image, extensive audience reach, and rich data insights, So-Young is well-positioned to expand both within the medical aesthetic industry and the broader consumption healthcare market. For investors, So-Young continues to stand out as a promising player in the fast-growing medical aesthetics sector.
So-Young International Inc. (Nasdaq: SY) reported its third quarter 2021 financial results, achieving total revenues of RMB431.5 million (US$67.0 million), a 20.0% year-over-year increase. Net income surged 649.5% to RMB6.8 million (US$1.1 million), while non-GAAP net income rose 9.6% to RMB28.9 million (US$4.5 million). Despite a decline in average mobile MAUs to 8.0 million, the number of paying medical service providers grew 18.2% to 4,841. The Company anticipates fourth-quarter revenues between RMB430 million and RMB450 million, reflecting a potential increase of up to 6.0% compared to 2020.
So-Young International Inc. (NASDAQ: SY) will release its third-quarter financial results for the period ending September 30, 2021, before U.S. markets open on November 19, 2021. An earnings conference call will follow at 7:00 AM EST, with preregistration required due to COVID-19 restrictions. So-Young continues to position itself as a leader in China's medical aesthetics industry, offering a vibrant social community and reliable information to users.
So-Young International Inc. (SY) reported second quarter 2021 revenues of RMB451.8 million (US$70.0 million), up 37.7% from RMB328.2 million in Q2 2020, exceeding prior guidance. Net income reached RMB57.6 million (US$8.9 million), a 26-fold increase year-over-year, while non-GAAP net income grew by 145.2% to RMB73.7 million (US$11.4 million). Average monthly active users rose by 47.5% to 10 million, and paying medical service providers increased by 31.2% to 4,899. The company expects Q3 revenues between RMB430 million and RMB450 million, reflecting continued growth prospects despite potential COVID-19 impacts.
So-Young International Inc. (NASDAQ: SY) will release its financial results for Q2 ended June 30, 2021, before U.S. markets open on September 10, 2021. A management conference call will occur at 7:30 AM U.S. Eastern Time the same day. Due to COVID-19, operator-assisted calls are unavailable; preregistration is required. So-Young is a leading social community in China's medical aesthetics sector, providing reliable information and curated service providers, positioning itself for growth in both aesthetic and healthcare service markets.
So-Young International Inc. (Nasdaq: SY) announced its decision to acquire a controlling interest in Wuhan Miracle Laser Systems for a total of RMB 791 million. This acquisition is part of So-Young's strategy to capitalize on the growth potential in China's medical aesthetics industry, particularly in non-surgical segments. The transaction is expected to close in Q3 2021, subject to customary conditions. So-Young aims to leverage this acquisition to enhance its operational capabilities and provide greater returns to shareholders.
So-Young International Inc. (Nasdaq: SY) reported its financial results for Q1 2021, showing a 97.0% revenue increase to RMB359.6 million (US$54.9 million) compared to RMB182.6 million in Q1 2020. However, the company posted a net loss of RMB46.3 million (US$7.1 million), up from a net loss of RMB35.9 million a year earlier. Key operational metrics revealed an average mobile MAU increase of 101.0% to 8.4 million and a 123.3% rise in users purchasing reservation services. The company forecasts revenues between RMB430 million and RMB450 million for Q2 2021.
So-Young International Inc. (NASDAQ: SY) will announce its Q1 2021 financial results on May 19, 2021, before U.S. markets open. A conference call will follow at 7:30 AM U.S. Eastern Time, requiring preregistration due to COVID-19 restrictions. Participants will receive dial-in information upon registration. An archived webcast will also be available post-conference. So-Young, a leader in the medical aesthetics industry in China, connects consumers and service providers, leveraging its trustworthy content and user insights to drive growth in the healthcare market.
So-Young International Inc. (Nasdaq: SY) responds to a short seller report from Blue Orca Capital, asserting that it contains inaccuracies about the company. In reaction to market disturbances, So-Young announced a share repurchase plan of up to US$70 million over 12 months to demonstrate confidence in its long-term prospects. The company emphasizes its leading position in China's medical aesthetics social community and invites third-party verification of its financial performance.
So-Young International Inc. (Nasdaq: SY) has filed its annual report on Form 20-F for the fiscal year ending December 31, 2020, with the Securities and Exchange Commission as of April 30, 2021. This report includes audited consolidated financial statements and can be accessed through the company's investor relations website. Shareholders can request a hard copy of the report free of charge via email. So-Young is noted as a significant social community in China's medical aesthetics industry, emphasizing its brand strength and market position.
So-Young International Inc. (Nasdaq: SY) reported its Q4 and full-year 2020 financial results, revealing Q4 revenues of RMB424.6 million (US$65.1 million), marking an 18.6% increase year-over-year. However, net income fell to RMB37.7 million (US$5.8 million) from RMB69.9 million in 2019. For the entire year, total revenues reached RMB1,295.0 million (US$198.5 million), up 12.4% from 2019, yet net income drastically decreased to RMB4.9 million (US$0.7 million). The company anticipates Q1 2021 revenues between RMB320 million and RMB330 million, reflecting a projected 75.3%-80.8% growth.
FAQ
What is the current stock price of So-Young International American Depository Shares (SY)?
What is the market cap of So-Young International American Depository Shares (SY)?
What does So-Young International Inc. do?
Where are So-Young's services available?
What are So-Young’s main revenue sources?
Who are So-Young's partners?
What recent financial achievements has So-Young reported?
What services does So-Young offer beyond medical aesthetics?
What recent leadership changes have occurred at So-Young?
What strategic developments has So-Young undertaken recently?
How does So-Young ensure the quality of its service providers?
What is the future outlook for So-Young?
